Product
Matching Placebo SC
1 clinical trial
1 indication
Indication
Myasthenia GravisClinical trial
A Phase 3, Multi-center, Randomized, Quadruple-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis (gMG)Status: Recruiting, Estimated PCD: 2024-04-01